Why the study?
Does intravaginal prostaglandin E2 gel reduce the need for surgical induction in patients with singleton viable pregnancies?
Does intravaginal prostaglandin E2 gel reduce the need for surgical induction in patients with singleton viable pregnancies?
Pre-induction vaginal prostaglandin E2 gel reduces the need for surgical induction and improves delivery outcomes in patients with singleton viable pregnancies.
May support PGE2 gel to avoid surgical induction with ripe cervix; leaves open randomized confirmation in singleton pregnancies.
Eight hundred and three patients with singleton viable pregnancies and fetal cephalic presentation were given prostaglandin E2 in viscous gel by intravaginal instillation the evening before planned surgical induction. When the cervix was 'ripe', surgical induction was avoided in 65.9 per cent of primigravidae and 87.5 per cent of multigravidae; the administration of epidural analgesia was less frequent, the rate of spontaneous vaginal delivery greater, the Caesarean section rate lower, and the state of the newborn at delivery better than in those patients who required surgical induction. Side effects attributable to the prostaglandin gel were rare as were complications.
No takes yet. Share an insight, caveat, or question.
MacKenzie et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: